VTP-43742

DRUG2 trials

Sponsors

Vitae Pharmaceuticals Inc., an Allergan affiliate

Conditions

Psoriasis

Phase 1

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

CompletedNCT02555709

Vitae Pharmaceuticals Inc., an Allergan affiliatePsoriasis

Start: 2015-08-31End: 2016-03-31Updated: 2018-10-30

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

CompletedNCT03724292

Vitae Pharmaceuticals Inc., an Allergan affiliatePsoriasis

Start: 2015-08-01End: 2016-03-08Updated: 2018-10-30

Related Papers

Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt inhibitor, in normal healthy volunteers

The Journal of Immunology2016-05-016 citations